All In MedTech

Device Trial Radar · NCT05321134

Evaluation of SINGLE PORT (SP) Robotic Technology in Colorectal Surgery

Last checked: Nov 20, 2026Latest source record: May 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

25

Planned (sponsor's estimate)

Start

Apr 28, 2022

Primary completion

Apr 2028

Study completion Apr 2028

Sponsor

Lead sponsor
University of California, DavisAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of California, San Francisco; Yale University; Henry Ford Hospital; University of Massachusetts, Worcester
First posted
Apr 11, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Currently a multiport robotic surgery platform (Intuitive Xi) is widely available and used for colorectal surgery indications. A Single port platform (Intuitive SP) is FDA approved for Head and Neck and Urology but has not been widely used in colorectal surgery. This study seeks to evaluate the safe and effective use of the SP platform for colorectal surgery indications.

Conditions

  • Colo-rectal Cancer
  • Rectal Prolapse
  • Colostomy Stoma
  • Colorectal Disorders

Interventions

  • Single port robotic colorectal surgical procedureDevice

    After screening and counseling, study subjects who wish to participate will undergo the colorectal surgical procedure (determined based on routine standard clinical care) using the alternate Intuitive Da Vinci Single Port SP system rather than the currently used multiport system, (Intuitive Da Vinci Multiport Xi System). Using standardized case report forms, the investigators will track clinical parameters and describe the safety \& quality event rate for SP platform transabdominal and transanal colorectal operations.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assess safety & quality event rate for SP platform transabdominal and transanal colorectal operationsTime frame: 30 days

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • UC Davis Medical Center

    Sacramento, California · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.